Synonyms: PEP-005 | Picato®
ingenol mebutate is an approved drug (FDA & EMA (2012))
Compound class:
Natural product
Comment: Ingenol mebutate is extracted from the plant Euphorbia peplus.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
A gel formulation containing ingenol mebutate is indicated for the topical treatment of actinic keratoses [3-4]. Ingenol mebutate is being further investigated in clinical trials for treatment of other skin lesions, including basal cell and squamous cell skin cancers. Click this link to view |
Mechanism Of Action and Pharmacodynamic Effects |
Ingenol mebutate is a pleiotropic effector which activates protein kinase C δ (PKCδ) [2]. Activation of PKCδ induces two main processes: rapid cell death and neutrophil infiltration at the site of application [1,1]. |
External links |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com European Medicines Agency (EMA) |